Duration of secretory IgM and IgA antibodies to respiratory syncytial virus in a community study in Guinea-Bissau

Medicin og biovidenskab

• secretory IgM 100%
• Guinea-Bissau 89%
• Secretory Immunoglobulin A 73%
• Respiratory Syncytial Viruses 66%
• Immunoglobulin M 49%
• Immunoglobulin A 33%
• Antibodies 31%
• Epidemics 26%
• Child 24%
• Antigens 22%
• Respiratory Syncytial Virus Infections 19%
• Respiratory Tract Infections 18%
• Infections 7%
• Acute-Phase Reaction 6%
• Suction 5%
• Antibody Formation 4%
• Outpatients 3%
• Referral and Consultation 3%
• Pediatrics 3%
• Confidence Intervals 3%
• Morbidity 3%
• Health 2%